Eukarÿs

🚀 Eukarÿs: A Landmark Year of Growth, Recognition, and Impact in 2025! As we reflect on 2025, we are incredibly proud of what Eukarÿs has accomplished in just our first year on the market. Our mission to revolutionize the biotech industry through biologics production has gained unprecedented momentum, thanks to the dedication of our team, the trust of our partners, and the support of the global life sciences community. 🌍 Commercial Traction: - 15 deals signed across 3 continents and 9 countries — a testament to the global demand for our groundbreaking technology - Now deployed or in predeployment in 5 top-20 pharma companies and 1 top-3 CDMO, setting the stage for transformative impact. 🏆 Industry Recognition: - Grand Prize Winner of BioTools Innovator, the only startup accelerator dedicated to life science tools. 440 candidates across 43 countries, 31 companies selected for the acceleration program, 5 finalists... 1 winner! by vote of 80 executives from industry leaders like Thermo Fisher Scientific and Sartorius. - Featured by NASDAQ in Times Square—a proud moment for our team and a symbol of our growing influence. - Selected by BARDA as one of 10 critical technology companies out of 330 candidates, recognized for our potential to enhance global preparedness against pandemics and bioterrorist threats. 👥 Strengthening Our Team & Governance: - Welcomed Herve Pouzoullic as Chief Commercial Officer, completing Eukarÿs highly experienced management team, together with Guillaume Prunier (CEO) and Philippe, H. Jais (CSO) - Strengthened the governance by welcoming Eric Drapé as board member, as well as Nicole Faust and Bryan Poltilove as strategic advisors. 💡 What’s Next? 2026 will be about scaling our impact, deepening partnerships, and continuing to innovate for a healthier, safer world. We’re just getting started! A heartfelt thank you to our team, partners, and supporters. Here’s to another year of breaking barriers and making history—together! #Eukarÿs #LifeSciences #Biomanufacturing #Innovation #Biotools #GlobalHealth #2025Recap

🎉 We are thrilled to announce the BioTools Innovator 2025 Grand Prize Winner: Eukarÿs! After presenting live on stage at our Capstone Event, Eukarys earned the audience vote and took home the $250,000 Grand Prize for their innovative approach to mRNA-based gene regulation. Congratulations to our outstanding Grand Prize finalists - Novilytic, Diagnostic Biochips, Inc., VisiCELL Medical Inc., and Likarda, Inc. - whose technologies represent exceptional innovation across life science tools, diagnostics, and biomanufacturing. Shoutout to our judges Daniel Friedman, Zara Solakhyan, Norio Hashimoto, and Brad Morie, MBA, CLP for asking the hard hitting questions! 🎥 We’re also excited to announce Osem Fluidics as our 2025 Best Video Winner with Aridica and ArgenTag recognized as this year’s Best Video finalists. The audience was wowed at the quality of videos in this year's competition. View the full press release and read about our winners here: https://lnkd.in/gSY7xDYe

🚀 Exciting news! 🚀 Eukarÿs is thrilled to announce that it is finalist of the BioTools Innovator 2025 competition. Once again, great milestone & great pride: Eukarÿs is the only biomanufacturing company in the top-1% of life science tools startups in 2025! At Eukarÿs, we believe that success is never achieved alone. Heartfelt THANK YOU to BioTools Innovator! And to our BioTools Innovator mentors Bryan Poltilove, Nicole Faust and Troels Jordansen, as well as to the entire BioTools Innovator team, Jim West III, MS, Ayelet Marom , Ph.D., PPM, Heather Lukas, Kathryn Zavala, and Council Mintz, CCRP, for their unwavering support, expertise, and partnership. Your dedication has been instrumental in our growth and success, helping us push the boundaries of bioproduction. Hard science and great commercial traction: this is what today defines Eukarÿs. Always having in mind that many milestones are still in front of us. we are fully focused on shaping the future of biomanufacturing! With Eukarÿs, the bioproduction revolution is on the move! 🚀 Guillaume Prunier Herve Pouzoullic Philippe, H. Jais #Biotech #Innovation #Partnership #Bioproduction

🚀 Exciting news! 🚀 Eukarÿs is thrilled to announce that it is finalist of the BioTools Innovator 2025 competition. Once again, great milestone & great pride: Eukarÿs is the only biomanufacturing company in the top-1% of life science tools startups in 2025! At Eukarÿs, we believe that success is never achieved alone. Heartfelt THANK YOU to BioTools Innovator! And to our BioTools Innovator mentors Bryan Poltilove, Nicole Faust and Troels Jordansen, as well as to the entire BioTools Innovator team, Jim West III, MS, Ayelet Marom , Ph.D., PPM, Heather Lukas, Kathryn Zavala, and Council Mintz, CCRP, for their unwavering support, expertise, and partnership. Your dedication has been instrumental in our growth and success, helping us push the boundaries of bioproduction. Hard science and great commercial traction: this is what today defines Eukarÿs. Always having in mind that many milestones are still in front of us. we are fully focused on shaping the future of biomanufacturing! With Eukarÿs, the bioproduction revolution is on the move! 🚀 Guillaume Prunier Herve Pouzoullic Philippe, H. Jais #Biotech #Innovation #Partnership #Bioproduction

Good news from the stars :-)

Eukarÿs featured at the BARDA Accelerator Network Showcase! We are thrilled to announce that Eukarÿs was the only non-US company highlighted at the prestigious BARDA Accelerator Network Showcase in Cambridge this week! A huge thank you to BARDA and the BioTools Innovator team, in particular Manbir Singh, Heather Lukas and Council Mintz, CCRP for this opportunity to showcase how the revolution Eukarÿs is bringing to biomanufacturing changes the game when it comes to react the most radiply to unforeseen health crisis. This revolution has a name: C3P3. C3P3 is a universal 5x to 7x cells productivity booster. It saves time, it saves money, it saves hard-to-express molecules. Zero investment, seamless deployment, working on all biologics: antibodies, proteins, ADC... We are really proud to stand alongside the world’s most innovative companies, driving progress and shaping the future of biodefense and medical countermeasures. #Biomanufacturing #Biotech #BARDA #Eukarys Philippe, H. Jais Herve Pouzoullic Guillaume Prunier

🌟 Exciting News! 🌟 We are thrilled to announce that Eric Drapé is joining the Board of Eukarÿs! 🎉 Eric brings a wealth of experience and expertise to our team. As a board member of Lonza and former Executive Vice President of Operations at Teva Pharmaceuticals, his strategic insights and leadership will be invaluable as we continue to grow and innovate. At Eukarÿs, we are revolutionizing biomanufacturing with a groundbreaking 5x to 7x increase in yields in mammalian cells, thanks to the world's first synthetic RNA polymerase. Eric's extensive background will undoubtedly accelerate our mission to transform the industry. Please join me in welcoming Eric Drapé to Eukarÿs. We are excited about the future and the contributions he will make to our mission. #Eukarÿs #BoardOfDirectors #Leadership #WelcomeEricDrape #Pharma #Biotech #Innovation #Biomanufacturing

We are incredibly excited to announce that Eukarys has been selected for the 2025 @BioToolsInnovator cohort as part of the @BARDA Vanguard specialty track! The process was extremely selective! - 440 applicants all around the world - only 31 have been selected by BioTools Innovator - over those, only 10 have been selected by @BARDA, the US federal department in charge of countermeasures agains biothreats - over which only 1 non-US company... Eukarÿs! Eukarÿs C3P3 technology multiplies biomanufacturing yields by 5x to 7x in mammalian cells, accelerating drug development by up to 6 months, drastically reducing the cost of vaccine / therapeutic production, and helping to produce hard-to-express biologics. This milestone is a huge accomplishment for our team and highlights the transformative potential of our platform. We want to thank our incredible board members, mentors, reviewers, and organizers for believing in our vision and supporting our journey. Together, we’re ready to make a real difference in people’s lives! We can't wait to get started! #BTI2025Cohort #LifeSciences #Biotools #ScientificTools #Diagnostics #Biotech #Research #Startups @BARDA Bryan Poltilove Guillaume Prunier Philippe, H. Jais Herve Pouzoullic https://lnkd.in/enjutque

🚀🚀🚀 We are thrilled to announce the signature of our 10th commercial contract... and that just 5 months after the release of our first product! - Top-5 pharma companies, CDMOs and CROs - All around the world: US, France, Switzerland, UK, Japan To all our partners: we are sincerely thankful for your trust, and are committed to bring you the three great advantages of our disruptive technology: 1. Acceleration of R&D 2. Substantial savings, OPEX and CAPEX 3. Save hard-to-produce molecules Biomanufacturing's paradigm is shifting, the revolution is ongoing! hashtag #Biomanufacturing #Biologics #CDMO #CRO #Biotech #Pharma